Serosurvey of Human T-Lymphotrophic Virus Type 1 Secondary Infection among People Living with Hiv/Aids in Dutse Metropolis, North-Western Nigeria
DOI:
https://doi.org/10.47430/ujmr.1831.015Keywords:
Human T-lymphotrophic virus -1, HIV/AIDS, CD4Abstract
Human T-lymphotrophic virus type 1 (HTLV-1) is a causative agent of tropic spastic paraparesis and adult T-cell leukaemia, Evidence is accumulating that HTLV-1 may be responsible for some degree of subclinical immune suppression that may results in increased rate of HIV. Sixty (60) people living with HIV/AIDS consisting of 20 males and 40 females were recruited in this study. HIV diagnosis was confirmed using Nigerian National Serial Algorithm for HIV test. ELISA technique was used for the detection of HTLV-1 IgG and IgM antibodies, and Cyflow partec was used for CD4 count. The prevalence of HTLV-1 IgG and IgM antibodies among HIV subjects was 15% and 6.6% respectively. Male patients have a percentage prevalence of 4(6.6%) and female 5(8.3%) of IgG antibodies, IgM antibodies prevalence was 2(3.3%) for male and female each respectively. CD4 Counts of the HIV subjects was evaluated which reveals that patients with counts 0-200cells/µl tested negative to HTLV-1 IgG and IgM antibodies. Conclusion: The percentage prevalence recorded in this study shows that HTLV-1 infection is relatively high compared to the previous studies even though limited information was obtained in relation to HIV/HTLV-1 co-infection in these study area.
Downloads
References
Analo HI, Akanmu AS, Akinsete I, et al.( 1998). Seroprevalence of HTLV-1 and HIV infection in blood donors and patients with lymphoid malignancies. Cent Afr J Med.;44(5):130-134
Arisawa, K., Soda, M., Endo, S et al., (2000). Evaluation of adult t-cell leukemia/lymphoma incidence and its impacts on non hodgkins in south western japan. Int.j. cancer; 85(3) 319-324.
https://doi.org/10.1002/(SICI)1097-0215(20000201)85:3<319::AID-IJC4>3.0.CO;2-B
Biswas H. H., Kaidarova Z., Garratty G., Gibble J. W., Newman B. H., Smith J. W., et al. (2010). Increased all-cause and cancer mortality in HTLV-II infection.J. Acquir. Immune. Defic. Syndr. 2010; 54 290-296.
https://doi.org/10.1097/QAI.0b013e3181cc5481
Brites, C, Alencar, R Gusmão, R Pedroso, C, Netto, E.M, Pedral-Sampalo, D, BardaróCo- R.(2001). Infection with HTLV-1 is associated with a shorter survival time for HIV-1-infected patients in Bahia, Brazil AIDS; 15 (15) pp. 2053-2055.
https://doi.org/10.1097/00002030-200110190-00023
Cook, LB., Elemans, M., Rowan, A.G., Asquith, B. (2013). HTLV1 persistence and pathogenesis virology 2013; 435(1) 131- 140.
https://doi.org/10.1016/j.virol.2012.09.028
Gessain, A., Cassar O. (2011). The prevalence and significance of HTLV1/II Seroindeterminate western blot patterns. Viruses; 3(8) 1320-1331.
https://doi.org/10.3390/v3081320
Gessain, A., Gallo, R. C., and Franchini, G. (1992). Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations. J Virol; 66(4), 2288-2295.
https://doi.org/10.1128/jvi.66.4.2288-2295.1992
Goncalves, DU., Proeitti., FA., Ribas, JG et al. (2010): Epidemiology, treatment, and prevention of human t-cell leukemia virus type1 associated diseases. Clinical microbial; 23(3)577-589
https://doi.org/10.1128/CMR.00063-09
Goon PK, Igakura T, Hanon E, Mosley AJ,Barfield A, Barnard AL, et al ., (2004). Human T celllymphotropic virus
Hlela C, Bittencourt A. (2014). Infective dermatitis associated with HTLV-1 mimics common eczemas in children and may be a prelude to severe systemic diseases. DermatolClin 2014; 32(2): 237-248.
https://doi.org/10.1016/j.det.2013.11.006
IARC. 2012. Human T-cell lymphotropic virus type 1. In Biological Agents. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 100B, 2012; Lyon, France: International Agency for Research on Cancer.pp. 315- 340.
Idris, D., Akinsegun, A., Adedoyin, D., Sarah, A., Adewumi, A. Seroprevalence of Human Tlymphotrophic antibodies among healthy blood donors at a tertiary center in lagos Nigeria. The pan Afr Med J 2014; 17 Pp 301
https://doi.org/10.11604/pamj.2014.17.301.4075
Mazanderani AFH, Ebrahim O. (2013). Progressive HIV infection in the presence of a raised CD4+ count: HIV/HTLV-1 co-infection. South Afr J HIV Med; 14(2):92-94.
https://doi.org/10.4102/sajhivmed.v14i2.85
Mohammed, MM., Adeola, F., Saleh, Y., Gireh, A.I., Mohammed, Y., Yakubu, MS., Omoruyi, EC., Ibrahim, MY, Rasheed, AB. (2016). Serosurvey of Human T-cell lymphotrophic virusI/II Among Blood donors in Gombe (Nigeria). Int. j. tranfus immune hematol; (6) 12-19.
https://doi.org/10.5348/ijbti-2016-24-OA-4
Piehl MR, Kaplan RL, Haber MH. Disseminated penicilliosis in a patient with acquired immunodeficiency syndrome. Arch Pathol Lab Med 1988; 112:1262-4
Porto MA, Muniz A, Oliveira J, Jr, Carvalho EM.( 2002). Clinical and immunological consequences of the association between HTLV-1 and strongyloidiasis. Rev Soc Bras Med Trop; 35:641-649.
https://doi.org/10.1590/S0037-86822002000600016
Proietti FA, Carneiro-Proietti ABF, Catalan- Soares B, Murphy EL. Global epidemiology of HTLV - I infection and associated disease. Oncegene 2005; 24(39):6058 - 606
https://doi.org/10.1038/sj.onc.1208968
Shmuel S, Vered Y, Eli S, Eilat S, Gad S, and Yechezkel S. (2009). Epidemiology of Human T-cellLymphotropicVirusType 1 Infection in Blood Donors, Israel Emerging Infectious Diseases; (15)7,
https://doi.org/10.3201/eid1507.080796
Sobesky, M. Couppie, P., Pradinaud, R., Godard, M.C., Alvarez, F. , Benoît, B. (2000). Coinfection with HIV and HTLV-I and survival in AIDS stage. French Guiana study Presse Med; 29 (March (8)) pp. 413-416.
Stienlauf S, Yahalom V, Shinar E, Sidi Y, Segal G, Schwartz E. (2013). Malignant diseases and mortality in blood donors infected with human T-lymphotropic virus type 1 in Israel. Int J Infect Dis 2013; 17(11): e1022-1024.
https://doi.org/10.1016/j.ijid.2013.03.012
Szczypinska E.M , Wallace M.R , Rich J.D. , Salas C.M. , Wainscoat B. Human T-cell lymphotropic viruses Medscape 2014.
Zane L, Sibon D, Mortreux F, et al. (2009). Clonal expansion of HTLV-1 infected cells depends on the CD4 versus CD8 phenotype. Front Biosci; 14:3935-3941
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 UMYU Journal of Microbiology Research (UJMR)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
